Researchers from Memorial Sloan Kettering Cancer Center (MSK) shared a promising treatment option for bladder cancer patients today at The European Society for Medical Oncology (ESMO) Congress 2022. Jonathan E. Rosenberg, ...
Sep 12, 2022
0
5
(HealthDay)—Radiation oncology (RO) and medical oncology (MO) academic faculty have increased the representation of women from 1970 through 2019, but inclusion of those underrepresented in medicine (URM) has lagged, according ...
Dec 21, 2021
0
3
Newly published research carried out using synthetic human bone marrow cells is paving the way for the development of safer and kinder treatments for children with leukemia.
Aug 17, 2022
0
56
Bone marrow transplantation is a life-saving therapy for many patients with blood cancers like leukemias and lymphomas. Currently, the gold standard blood-generating stem cells are obtained from a donor, a sibling, with a ...
Oct 7, 2015
0
15
(HealthDay) -- Patients with early-stage papillary thyroid cancer (PTC) may benefit from the use of a patient-directed computerized decision aid (DA) to provide medical knowledge and resolve decisional conflicts regarding ...
Jul 6, 2012
0
0
Scientists at Mount Sinai have created a library of well-characterized human induced pluripotent stem cell (hiPSC) lines from clinically healthy humans, which can serve as a valuable resource of normal controls for in vitro ...
Nov 4, 2021
0
10
Male doctors make more money than their female counterparts, even when factoring in medical specialty, title, work hours, productivity and a host of other factors, according to a comprehensive new analysis from researchers ...
Jun 12, 2012
1
0
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival, researchers said at the ESMO 16th World Congress on Gastrointestinal Cancer ...
Jun 28, 2014
0
0
Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from ...
Dec 8, 2011
0
0
A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive ...
Sep 19, 2021
0
17
